Skip to content

Clinical trials

Phase 1 Urinary Bladder Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 1 Clear all

264 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20015
20021
20035
20046
20054
20067
20076
20083
20095
20105
20119
20127
20137
20145
201513
201615
201713
201810
201918
202018
202114
202215
202316
202413
202513
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed135
Terminated32
Recruiting28
Active, not recruiting26
Unknown status22
Withdrawn13
Not yet recruiting7
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)17
Memorial Sloan Kettering Cancer Center7
M.D. Anderson Cancer Center6
Pfizer6
Eli Lilly and Company5
H. Lee Moffitt Cancer Center and Research Institute4
Jonsson Comprehensive Cancer Center4
MacroGenics4
University of California, Davis4
Celldex Therapeutics3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms264
Carcinoma, Non-Small-Cell Lung77
Breast Neoplasms68
Ovarian Neoplasms65
Stomach Neoplasms53
Lung Neoplasms52
Pancreatic Neoplasms52
Prostatic Neoplasms52
Carcinoma, Renal Cell51
Colorectal Neoplasms51

Trials

Showing 26 to 50 of 264. Each trial links to its page on Pharma Observatory.

164 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.